Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.15 USD
Change Today +0.003 / 2.04%
Volume 23.5K
RGDX On Other Exchanges
As of 10:24 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas A. Bologna

Chairman and Chief Executive Officer, Response Genetics, Inc
AgeTotal Calculated CompensationThis person is connected to 16 board members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Thomas A. Bologna, also known as Tom, has been the Chairman and Chief Executive Officer of Response Genetics, Inc., since December 21, 2011. Mr. Bologna served as the Chief Executive Officer and President of Orchid Cellmark Inc. since April 25, 2006. He served as the President and Chief Executive Officer of Orchid Cellmark Ltd., a subsidiary of Orchid Cellmark Inc. He served as President and Chief Executive Officer of Quorex Pharmaceuticals, Inc. since September ...

Read Full Background

Corporate Headquarters*

1640 Marengo Street
Los Angeles, California 90033

United States

Phone: 323-224-3900
Fax: 323-224-3096

Board Members Memberships*

Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Chairman and Chief Executive Officer
Director, Member of Audit Committee and Member of Remuneration Committee


New York University
New York University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$767,909

Stock Options*

All Other Compensation$144,057
Exercisable Options1,117,014
Unexercisable Options414,986
Total Number of Options1,532,000

Total Compensation*

Total Annual Cash Compensation$911,966
Total Short Term Compensation$767,909
Other Long Term Compensation$144,057
Total Calculated Compensation$1,053,846
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGDX:US $0.15 USD +0.003


Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESPONSE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at